GOLDMAN SACHS GROUP INC
Position in CRL — Charles River Laboratories International, Inc.
CIK 886982
NEW YORK, NY
Position in CRL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$71,540,579
+$8,181,942 QoQ
Shares Held
414,728
+30.6% QoQ
Ownership
0.861%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.00134063771918.ToString("F0")%
Shared 0.ToString("F0")%
None 1.9986593622808202.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Derivatives in CRL
reported options exposure · as of Dec 31, 2021CallValue
$3,014,240
CallShares
8,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. CRL ranks #16 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,157,226 | $1,551,871,293 | |
| 2 | DHR |
Danaher Corp /De/
|
4,609,288 | $873,921,002 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
387,844 | $489,148,850 | |
| 4 | GH |
Guardant Health, Inc.
|
4,435,839 | $409,738,446 | |
| 5 | A |
Agilent Technologies, Inc.
|
3,577,648 | $407,780,316 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
716,921 | $402,830,739 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,348,694 | $264,317,047 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,177,280 | $200,773,329 |
All Filings in CRL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71,540,579 | 414,728 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $63,358,637 | 317,619 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $37,427,108 | 239,212 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $57,512,496 | 379,045 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $150,141,892 | 997,488 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $36,315,618 | 196,726 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $30,146,651 | 153,052 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $45,107,981 | 218,356 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $40,436,847 | 149,241 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $36,498,741 | 154,394 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $32,104,658 | 163,816 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $60,128,136 | 285,984 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $41,078,239 | 203,539 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $24,347,056 | 111,735 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $23,296,002 | 118,374 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $25,534,109 | 119,335 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $43,052,690 | 151,610 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,014,240 | 8,000 | Call | Defined | 2022-02-17 | |
| 2021-12-31 | $46,195,110 | 122,605 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $50,876,019 | 123,285 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,477,248 | 9,400 | Call | Defined | 2021-08-13 | |
| 2021-06-30 | $44,190,272 | 119,459 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $56,543,222 | 195,091 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $38,373,747 | 153,581 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $62,171,845 | 274,550 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $48,877,453 | 280,341 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $48,211,588 | 381,995 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||